Claris Lifesciences

Claris Lifesciences Limited is a multi-business enterprise and the Holding Company of Claris Injectables - a wholly-owned subsidiary dealing in Specialty Injectables business, collectively ‘Claris’; and Claris Otsuka - a Joint Venture with Japanese Otsuka Pharmaceutical Factory, Inc. & Mitsui & Co. Ltd. for Infusion business in India & Emerging Markets. Coupled with our strength of technical know-how & expertise in manufacturing and marketing injectables products, our growth is catapulted with the support of a team of scientists, pharmaceutical experts, and management professionals, who work diligently to take the organisation to newer heights year-on-year. Claris Injectables Claris manufactures and/or markets products across multiple delivery systems, markets, and therapeutic segments, including anesthesia & analgesics, blood products, anti-infectives, critical care, and nephrology. A significant majority of these products are generic drugs, capable of being directly injected into the human body, predominantly used in the treatment of critical illnesses. The customer base primarily includes government and semi-government institutions, group corporate hospitals, standalone prominent hospitals, and nursing homes. With emphasis on quality, technology, and innovation, we offer a range of niche technology-driven injectables products across delivery systems, such as bags (PVC & NPVC), vials, ampoules, glass bottles, etc.